Blank, David
3 papers on CoChatORCID 0000-0001-6360-7457
Most cited papers
- Verified
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 3,163
- Verified
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 638
- Verified
Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula
Sniderman, A. D., Blank, D., Zakarian, R., Bergeron, J., & Frohlich, J. (2003) · Clinical Biochemistry
MicroRNA in disease regulationRetinal Diseases and Treatments
Cited by 100
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free